Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Antimicrobial Resistance & Infection Control
Published in: Antimicrobial Resistance & Infection Control 1/2016

Open Access 01-12-2016 | Review

Modern technologies for improving cleaning and disinfection of environmental surfaces in hospitals

Author: John M. Boyce

Published in: Antimicrobial Resistance & Infection Control | Issue 1/2016

Login to get access

Abstract

Experts agree that careful cleaning and disinfection of environmental surfaces are essential elements of effective infection prevention programs. However, traditional manual cleaning and disinfection practices in hospitals are often suboptimal. This is often due in part to a variety of personnel issues that many Environmental Services departments encounter. Failure to follow manufacturer’s recommendations for disinfectant use and lack of antimicrobial activity of some disinfectants against healthcare-associated pathogens may also affect the efficacy of disinfection practices.
Improved hydrogen peroxide-based liquid surface disinfectants and a combination product containing peracetic acid and hydrogen peroxide are effective alternatives to disinfectants currently in widespread use, and electrolyzed water (hypochlorous acid) and cold atmospheric pressure plasma show potential for use in hospitals. Creating “self-disinfecting” surfaces by coating medical equipment with metals such as copper or silver, or applying liquid compounds that have persistent antimicrobial activity surfaces are additional strategies that require further investigation.
Newer “no-touch” (automated) decontamination technologies include aerosol and vaporized hydrogen peroxide, mobile devices that emit continuous ultraviolet (UV-C) light, a pulsed-xenon UV light system, and use of high-intensity narrow-spectrum (405 nm) light. These “no-touch” technologies have been shown to reduce bacterial contamination of surfaces. A micro-condensation hydrogen peroxide system has been associated in multiple studies with reductions in healthcare-associated colonization or infection, while there is more limited evidence of infection reduction by the pulsed-xenon system. A recently completed prospective, randomized controlled trial of continuous UV-C light should help determine the extent to which this technology can reduce healthcare-associated colonization and infections.
In conclusion, continued efforts to improve traditional manual disinfection of surfaces are needed. In addition, Environmental Services departments should consider the use of newer disinfectants and no-touch decontamination technologies to improve disinfection of surfaces in healthcare.
Literature
1.
Rutala WA, Weber DJ. Disinfectants used for environmental disinfection and new room decontamination technology. Am J Infect Control. 2013;41:S36–41.PubMedCrossRef
2.
Donskey CJ. Does improving surface cleaning and disinfection reduce health care-associated infections? Am J Infect Control. 2013;41:S12–9.PubMedCrossRef
3.
Dancer SJ. Controlling hospital-acquired infection: focus on the role of the environment and new technologies for decontamination. Clin Microbiol Rev. 2014;27:665–90.PubMedPubMedCentralCrossRef
4.
Han JH, Sullivan N, Leas BF, Pegues DA, Kaczmarek JL, Umscheid CA. Cleaning hospital room surfaces to prevent health care-associated infections. a technical brief. Ann Intern Med. 2015;163:598-607.
5.
Carling PC, Bartley JM. Evaluating hygienic cleaning in health care settings: what you do not know can harm your patients. Am J Infect Control. 2010;38:S41–50.PubMedCrossRef
6.
Boyce JM, Havill NL, Lipka A, Havill H, Rizvani R. Variations in hospital daily cleaning practices. Infect Control Hosp Epidemiol. 2010;31:99–101.PubMedCrossRef
7.
Sitzlar B, Deshpande A, Fertelli D, Kundrapu S, Sethi AK, Donskey CJ. An Environmental Disinfection Odyssey: Evaluation of Sequential Interventions to Improve Disinfection of Clostridium difficile Isolation Rooms. Infect Control Hosp Epidemiol. 2013;34:459–65.PubMedCrossRef
8.
Appelbaum E, Berg P, Frost A, Preuss G, Appelbaum E. The effects of work restructuring on low-wage, low-skilled workers in U.S. hospitals. In: Bernhadt A, Murnane R, editors. Low-wage America: How employers are reshaping opportunity in the workplace. New York: Russel Sage Foundation; 2003. p. 77–117.
9.
Zuberi DM, Ptashnick MB. The deleterious consequences of privatization and outsourcing for hospital support work: the experiences of contracted-out hospital cleaners and dietary aids in Vancouver, Canada. Soc Sci Med. 2011;72:907–11.PubMedCrossRef
10.
Zoutman DE, Ford BD, Sopha K. Environmental cleaning resources and activities in Canadian acute care hospitals. Am J Infect Control. 2014;42:490–4.PubMedCrossRef
11.
Dumigan DG, Boyce JM, Havill NL, Golebiewski M, Balogun O, Rizvani R. Who is really caring for your environment of care? Developing standardized cleaning procedures and effective monitoring techniques. Am J Infect Control. 2010;38:387–92.PubMedCrossRef
12.
Anderson RE, Young V, Stewart M, Robertson C, Dancer SJ. Cleanliness audit of clinical surfaces and equipment: who cleans what? J Hosp Infect. 2011;78:178–81.PubMedCrossRef
13.
Ali S, Moore G, Wilson AP. Effect of surface coating and finish upon the cleanability of bed rails and the spread of Staphylococcus aureus. J Hosp Infect. 2012;80:192–8.PubMedCrossRef
14.
Cadnum JL, Hurless KN, Kundrapu S, Donskey CJ. Transfer of Clostridium difficile spores by nonsporicidal wipes and improperly used hypochlorite wipes: practice + product = perfection. Infect Control Hosp Epidemiol. 2013;34:441–2.PubMedCrossRef
15.
Siani H, Cooper C, Maillard JY. Efficacy of “sporicidal” wipes against Clostridium difficile. Am J Infect Control. 2011;39:212–8.PubMedCrossRef
16.
Engelbrecht K, Ambrose D, Sifuentes L, Gerba C, Weart I, Koenig D. Decreased activity of commercially available disinfectants containing quaternary ammonium compounds when exposed to cotton towels. Am J Infect Control. 2013;41:908–11.PubMedCrossRef
17.
Boyce JM, Sullivan L, Booker A, Baker J. Quaternary ammonium disinfectant issues encountered in an environmental services department. Infect Control Hosp Epidemiol. 2016;37:340–2.PubMedCrossRef
18.
Ramm L, Siani H, Wesgate R, Maillard JY. Pathogen transfer and high variability in pathogen removal by detergent wipes. Am J Infect Control. 2015;43:724–8.PubMedCrossRef
19.
Weber DJ, Rutala WA, Sickbert-Bennett E. Outbreaks associated with contaminated antiseptics and disinfectants. Antimicrob Agents Chemother. 2007;51:4217–24.PubMedPubMedCentralCrossRef
20.
Boyce JM, Havill NL, Tetro J, Sattar SA. Bacterial growth in an in-use hospital-grade quaternary ammonium-based disinfectant. Presented at the 21st Annual Scientific Meeting of the Society for Healthcare Epidemiology of America, April 2, 2011, Dallas, TX, abstr 113, 2011.
21.
Kampf G, Degenhardt S, Lackner S, Jesse K, von Baum H, Ostermeyer C. Poorly processed reusable surface disinfection tissue dispensers may be a source of infection. BMC Infect Dis. 2014;14:37.PubMedPubMedCentralCrossRef
22.
Eckstein BC, Adams DA, Eckstein EC, Rao A, Sethi AK, Yadavalli GK, et al. Reduction of Clostridium difficile and vancomycin-resistant Enterococcus contamination of environmental surfaces after an intervention to improve cleaning methods. BMC Infect Dis. 2007;7:61.PubMedPubMedCentralCrossRef
23.
French GL, Otter JA, Shannon KP, Adams NMT, Watling D, Parks MJ. Tackling contamination of the hospital environment by methicillin-resistant Staphylococcus aureus (MRSA): a comparison between conventional terminal cleaning and hydrogen peroxide vapour decontamination. J Hosp Infect. 2004;57:31–7.PubMedCrossRef
24.
Sigler V, Hensley S. Persistence of mixed staphylococci assemblages following disinfection of hospital room surfaces. J Hosp Infect. 2013;83:253–6.PubMedCrossRef
25.
Mitchell BG, Digney W, Locket P, Dancer SJ. Controlling methicillin-resistant Staphylococcus aureus (MRSA) in a hospital and the role of hydrogen peroxide decontamination: an interrupted time series analysis. BMJ Open. 2014;4:e004522.PubMedPubMedCentralCrossRef
26.
Hayden MK, Bonten MJ, Blom DW, Lyle EA, van de Vijver DA, Weinstein RA. Reduction in acquisition of vancomycin-resistant Enterococcus after enforcement of routine environmental cleaning measures. Clin Infect Dis. 2006;42:1552–60.PubMedCrossRef
27.
Manian FA, Griesnauer S, Senkel D. Impact of terminal cleaning and disinfection on isolation of Acinetobacter baumannii complex from inanimate surfaces of hospital rooms by quantitative and qualitative methods. Am J Infect Control. 2013;41:384–5.PubMedCrossRef
28.
Strassle P, Thom KA, Johnson JK, Leekha S, Lissauer M, Zhu J, et al. The effect of terminal cleaning on environmental contamination rates of multidrug-resistant Acinetobacter baumannii. Am J Infect Control. 2012;40:1005–7.PubMedCrossRef
29.
Goodman ER, Platt R, Bass R, Onderdon AB, Yokoe DS, Huang SS. Impact of an environmental cleaning intervention on the presence of methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci on surfaces in intenstive care unit rooms. Infect Control Hosp Epidemiol. 2008;29:593–9.PubMedPubMedCentralCrossRef
30.
Passaretti CL, Otter JA, Reich NG, Myers J, Shepard J, Ross T, et al. An evaluation of environmental decontamination with hydrogen peroxide vapor for reducing the risk of patient acquisition of multidrug-resistant organisms. Clin Infect Dis. 2013;56:27–35.PubMedCrossRef
31.
Mitchell BG, Dancer SJ, Anderson M, Dehn E. Risk of organism acquisition from prior room occupants: a systematic review and meta-analysis. J Hosp Infect. 2015;91:211–7.PubMedCrossRef
32.
Carling PC, Briggs JL, Perkins J, Highlander D. Improved cleaning of patient rooms using a new targeting method. Clin Infect Dis. 2006;42:385–8.PubMedCrossRef
33.
Boyce JM, Havill NL, Dumigan DG, Golebiewski M, Balogun O, Rizvani R. Monitoring the effectiveness of hospital cleaning practices using an ATP bioluminescence assay. Infect Control Hosp Epidemiol. 2009;30:678–84.PubMedCrossRef
34.
Rupp ME, Fitzgerald T, Sholtz L, Lyden E, Carling P. Maintain the gain: program to sustain performance improvement in environmental cleaning. Infect Control Hosp Epidemiol. 2014;35:866–8.PubMedCrossRef
35.
Alfa MJ, Lo E, Wald A, Dueck C, Degagne P, Harding GK. Improved eradication of Clostridium difficile spores from toilets of hospitalized patients using an accelerated hydrogen peroxide as the cleaning agent. BMC Infect Dis. 2010;10:268.PubMedPubMedCentralCrossRef
36.
Rutala WA, Gergen MF, Weber DJ. Efficacy of improved hydrogen peroxide against important healthcare-associated pathogens. Infect Control Hosp Epidemiol. 2012;33:1159–61.PubMedCrossRef
37.
Boyce JM, Havill NL. Evaluation of a new hydrogen peroxide wipe disinfectant. Infect Control Hosp Epidemiol. 2013;34:521–3.PubMedCrossRef
38.
Alfa MJ, Lo E, Olson N, MacRae M, Buelow-Smith L. Use of a daily disinfectant cleaner instead of a daily cleaner reduced hospital-acquired infection rates. Am J Infect Control. 2015;43:141–6.PubMedCrossRef
39.
Rutala WA, Gergen MF, Sickbert-Bennett EE, Williams DA, Weber DJ. Effectiveness of improved hydrogen peroxide in decontaminating privacy curtains contaminated with multidrug-resistant pathogens. Am J Infect Control. 2014;42:426–8.PubMedCrossRef
40.
Chiu S, Skura B, Petric M, McIntyre L, Gamage B, Isaac-Renton J. Efficacy of common disinfectant/cleaning agents in inactivating murine norovirus and feline calicivirus as surrogate viruses for human norovirus. Am J Infect Control. 2015;43:1208–12.PubMedCrossRef
41.
Carling PC, Perkins J, Ferguson J, Thomasser A. Evaluating a new paradigm for comparing surface disinfection in clinical practice. Infect Control Hosp Epidemiol. 2014;35:1349–55.PubMedCrossRef
42.
Deshpande A, Mana TS, Cadnum JL, Jencson AC, Sitzlar B, Fertelli D, et al. Evaluation of a sporicidal peracetic acid/hydrogen peroxide-based daily disinfectant cleaner. Infect Control Hosp Epidemiol. 2014;35:1414–6.PubMedCrossRef
43.
Meakin NS, Bowman C, Lewis MR, Dancer SJ. Comparison of cleaning efficacy between in-use disinfectant and electrolysed water in an English residential care home. J Hosp Infect. 2012;80:122–7.PubMedCrossRef
44.
Fertelli D, Cadnum JL, Nerandzic MM, Sitzlar B, Kundrapu S, Donskey CJ. Effectiveness of an electrochemically activated saline solution for disinfection of hospital equipment. Infect Control Hosp Epidemiol. 2013;34:543–4.PubMedCrossRef
45.
Stewart M, Bogusz A, Hunter J, Devanny I, Yip B, Reid D, et al. Evaluating use of neutral electrolyzed water for cleaning near-patient surfaces. Infect Control Hosp Epidemiol. 2014;35:1505–10.PubMedCrossRef
46.
Cahill OJ, Claro T, O'Connor N, Cafolla AA, Stevens NT, Daniels S, et al. Cold air plasma to decontaminate inanimate surfaces of the hospital environment. Appl Environ Microbiol. 2014;80:2004–10.PubMedPubMedCentralCrossRef
47.
O'Connor N, Cahill O, Daniels S, Galvin S, Humphreys H. Cold atmospheric pressure plasma and decontamination. Can it contribute to preventing hospital-acquired infections? J Hosp Infect. 2014;88:59–65.PubMedCrossRef
48.
Claro T, Cahill OJ, O'Connor N, Daniels S, Humphreys H. Cold-air atmospheric pressure plasma against Clostridium difficile spores: a potential alternative for the decontamination of hospital inanimate surfaces. Infect Control Hosp Epidemiol. 2015;36:742–4.PubMedCrossRef
49.
Unal N, Yanik K, Karadag A, Odabasi H, Esen S, Gunaydin M. Evaluation of the efficacy of akacid plus(R) fogging in eradicating causative microorganism in nosocomial infections. Int J Clin Exp Med. 2014;7:5867–71.PubMedPubMedCentral
50.
Moore G, Griffith C. A laboratory evaluation of the decontamination properties of microfibre cloths. J Hosp Infect. 2006;64:379–85.PubMedCrossRef
51.
Rutala WA, Gergen MF, Weber DJ. Microbiologic evaluation of microfiber mops for surface disinfection. Am J Infect Control. 2007;35:569–73.PubMedCrossRef
52.
Moore G, Hall TJ, Wilson AP, Gant VA. The efficacy of the inorganic copper-based biocide CuWB50 is compromised by hard water. Lett Appl Microbiol. 2008;46:655–60.PubMedCrossRef
53.
Ali S, Moore G, Wilson AP. Spread and persistence of Clostridium difficile spores during and after cleaning with sporicidal disinfectants. J Hosp Infect. 2011;79:97–8.PubMedCrossRef
54.
Bergen LK, Meyer M, Hog M, Rubenhagen B, Andersen LP. Spread of bacteria on surfaces when cleaning with microfibre cloths. J Hosp Infect. 2009;71:132–7.PubMedCrossRef
55.
Trajtman AN, Manickam K, Alfa MJ. Microfiber cloths reduce the transfer of Clostridium difficile spores to environmental surfaces compared with cotton cloths. Am J Infect Control. 2015;43:686–9.PubMedCrossRef
56.
Weber DJ, Rutala WA. Self-disinfecting surfaces: review of current methodologies and future prospects. Am J Infect Control. 2013;41:S31–5.PubMedCrossRef
57.
Humphreys H. Self-disinfecting and microbiocide-impregnated surfaces and fabrics: what potential in interrupting the spread of healthcare-associated infection? Clin Infect Dis. 2014;58:848–53.PubMedCrossRef
58.
Schmidt MG, Attaway HH, Sharpe PA, John Jr J, Sepkowitz KA, Morgan A, et al. Sustained reduction of microbial burden on common hospital surfaces through introduction of copper. J Clin Microbiol. 2012;50:2217–23.PubMedPubMedCentralCrossRef
59.
Schmidt MG, Attaway Iii HH, Fairey SE, Steed LL, Michels HT, Salgado CD. Copper continuously limits the concentration of bacteria resident on bed rails within the intensive care unit. Infect Control Hosp Epidemiol. 2013;34:530–3.PubMedCrossRef
60.
Salgado CD, Sepkowitz KA, John JF, Cantey JR, Attaway HH, Freeman KD, et al. Copper surfaces reduce the rate of healthcare-acquired infections in the intensive care unit. Infect Control Hosp Epidemiol. 2013;34:479–86.PubMedCrossRef
61.
Schweizer M, Graham M, Ohl M, Heilmann K, Boyken L, Diekema D. Novel hospital curtains with antimicrobial properties: a randomized, controlled trial. Infect Control Hosp Epidemiol. 2012;33:1081–5.PubMedCrossRef
62.
Kotsanas D, Wijesooriya WR, Sloane T, Stuart RL, Gillespie EE. The silver lining of disposable sporicidal privacy curtains in an intensive care unit. Am J Infect Control. 2014;42:366–70.PubMedCrossRef
63.
Baxa D, Shetron-Rama L, Golembieski M, Golembieski M, Jain S, Gordon M, et al. In vitro evaluation of a novel process for reducing bacterial contamination of environmental surfaces. Am J Infect Control. 2011;39:483–7.PubMedCrossRef
64.
Boyce JM, Havill NL, Guercia KA, Schweon SJ, Moore BA. Evaluation of two organosilane products for sustained antimicrobial activity on high-touch surfaces in patient rooms. Am J Infect Control. 2014;42:326–8.PubMedCrossRef
65.
Tamimi AH, Carlino S, Gerba CP. Long-term efficacy of a self-disinfecting coating in an intensive care unit. Am J Infect Control. 2014;42:1178–81.PubMedCrossRef
66.
Hedin G, Rynback J, Lore B. Reduction of bacterial surface contamination in the hospital environment by application of a new product with persistent effect. J Hosp Infect. 2010;75:112–5.PubMedCrossRef
67.
Page K, Wilson M, Parkin IP. Antimicrobial surfaces and their potential in reducing the role of the inanimate environment in the incidence of hospital-acquired infections. J Mater Chem. 2009;19:3819–31.CrossRef
68.
Park GW, Cho M, Cates EL, Lee D, Oh BT, Vinje J, et al. Fluorinated TiO(2) as an ambient light-activated virucidal surface coating material for the control of human norovirus. J Photochem Photobiol B. 2014;140:315–20.PubMedCrossRef
69.
Bogdan J, Zarzynska J, Plawinska-Czarnak J. Comparison of Infectious Agents Susceptibility to Photocatalytic Effects of Nanosized Titanium and Zinc Oxides: A Practical Approach. Nanoscale Res Lett. 2015;10:1023.PubMed
70.
de Jong B, van Zanten ARH. Effect of MVX (titanium dioxide) on the microbial colonization of surfaces in an intensive care unit. Clinical Trials.gov identifier: NCT02348346, 2015.
71.
Otter JA, Yezli S, Perl TM, Barbut F, French GL. The role of ‘no-touch’ automated room disinfection systems in infection prevention and control. J Hosp Infect. 2013;83:1–13.PubMedCrossRef
72.
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health. Non-manual techniques for room disinfection in healthcare facilities: a review of clinical effectiveness and guidelines. 2014.
73.
Andersen BM, Rasch M, Hochlin K, Jensen FH, Wismar P, Fredriksen JE. Decontamination of rooms, medical equipment and ambulances using an aerosol of hydrogen peroxide disinfectant. J Hosp Infect. 2006;62:149–55.PubMedCrossRef
74.
Shapey S, Machin K, Levi K, Boswell TC. Activity of a dry mist hydrogen peroxide system against environmental Clostridium difficile contamination in elderly care wards. J Hosp Infect. 2008;70:136–41.PubMedCrossRef
75.
Bartels MD, Kristoffersen K, Slotsbjerg T, Rohde SM, Lundgren B, Westh H. Environmental meticillin-resistant Staphylococcus aureus (MRSA) disinfection using dry-mist-generated hydrogen peroxide. J Hosp Infect. 2008;70:35–41.PubMedCrossRef
76.
Barbut F, Menuet D, Verachten M, Girou E. Comparison of the efficacy of a hydrogen peroxide dry-mist disinfection system and sodium hypochlorite solution for eradication of Clostridium difficile spores. Infect Control Hosp Epidemiol. 2009;30:507–14.PubMedCrossRef
77.
Piskin N, Celebi G, Kulah C, Mengeloglu Z, Yumusak M. Activity of a dry mist-generated hydrogen peroxide disinfection system against methicillin-resistant Staphylococcus aureus and Acinetobacter baumannii. Am J Infect Control. 2011;39:757–62.PubMedCrossRef
78.
Landelle C, Legrand P, Lesprit P, Cizeau F, Ducellier D, Gouot C, et al. Protracted outbreak of multidrug-resistant Acinetobacter baumannii after intercontinental transfer of colonized patients. Infect Control Hosp Epidemiol. 2013;34:119–24.PubMedCrossRef
79.
Best EL, Parnell P, Thirkell G, Verity P, Copland M, Else P, et al. Effectiveness of deep cleaning followed by hydrogen peroxide decontamination during high Clostridium difficile infection incidence. J Hosp Infect. 2014;87:25–33.PubMedCrossRef
80.
Fichet G, Antioga K, Comoy E, Deslys JP, McDonnell G. Prion inactivation using a new gaseous hydrogen peroxide sterilisation process. J Hosp Infect. 2007;67:278–86.PubMedCrossRef
81.
Heckert RA, Best M, Jordan LT, Dulac GC, Eddington DL, Sterritt WG. Efficacy of vaporized hydrogen peroxide against exotic animal viruses. Appl Environ Microbiol. 1997;63:3916–8.PubMedPubMedCentral
82.
Rogers JV, Sabourin CL, Choi YW, Richter WR, Rudnicki DC, Riggs KB, et al. Decontamination assessment of Bacillus anthracis, Bacillus subtilis, and Geobacillus stearothermophilus spores on indoor surfaces using a hydrogen peroxide gas generator. J Appl Microbiol. 2005;99:739–48.PubMedCrossRef
83.
Pottage T, Richardson C, Parks S, Walker JT, Bennett AM. Evaluation of hydrogen peroxide gaseous disinfection systems to decontaminate viruses. J Hosp Infect. 2010;74:55–61.PubMedCrossRef
84.
Ray A, Perez F, Beltramini AM, Jakubowycz M, Dimick P, Jacobs MR, et al. Use of vaporized hydrogen peroxide decontamination during an outbreak of multidrug-resistant Acinetobacter baumannii infection at a long-term acute care hospital. Infect Control Hosp Epidemiol. 2010;31:1236–41.PubMedPubMedCentralCrossRef
85.
Galvin S, Boyle M, Russell RJ, Coleman DC, Creamer E, O'Gara JP, et al. Evaluation of vaporized hydrogen peroxide, Citrox and pH neutral Ecasol for decontamination of an enclosed area: a pilot study. J Hosp Infect. 2012;80:67–70.PubMedCrossRef
86.
Chmielarczyk A, Higgins PG, Wojkowska-Mach J, Synowiec E, Zander E, Romaniszyn D, et al. Control of an outbreak of Acinetobacter baumannii infections using vaporized hydrogen peroxide. J Hosp Infect. 2012;81:239–45.PubMedCrossRef
87.
Bates CJ, Pearse R. Use of hydrogen peroxide vapour for environmental control during a Serratia outbreak in a neonatal intensive care unit. J Hosp Infect. 2005;61:364–6.PubMedCrossRef
88.
Hall L, Otter JA, Chewins J, Wengenack NL. Use of hydrogen peroxide vapor for deactivation of Mycobacterium tuberculosis in a biological safety cabinet and a room. J Clin Microbiol. 2007;45:810–5.PubMedPubMedCentralCrossRef
89.
Hall L, Otter JA, Chewins J, Wengenack NL. Deactivation of the dimorphic fungi Histoplasma capsulatum, Blastomyces dermatitidis and Coccidioides immitis using hydrogen peroxide vapor. Med Mycol. 2008;46:189–91.PubMedCrossRef
90.
Boyce JM, Havill NL, Otter JA, McDonald LC, Adams NMT, Cooper T, et al. Impact of hydrogen peroxide vapor room decontamination on Clostridium difficile environmental contamination and transmission in a healthcare setting. Infect Control Hosp Epidemiol. 2008;29:723–9.PubMedCrossRef
91.
Otter JA, French GL. Survival of nosocomial bacteria and spores on surfaces and inactivation by hydrogen peroxide vapor. J Clin Microbiol. 2009;47:205–7.PubMedPubMedCentralCrossRef
92.
Manian FA, Griesenauer S, Senkel D, Setzer JM, Doll SA, Perry AM, et al. Isolation of Acinetobacter baumannii complex and methicillin-resistant Staphylococcus aureus from hospital rooms following terminal cleaning and disinfection: can we do better? Infect Control Hosp Epidemiol. 2011;32:667–72.PubMedCrossRef
93.
Barbut F, Yezli S, Mimoun M, Pham J, Chaouat M, Otter JA. Reducing the spread of Acinetobacter baumannii and methicillin-resistant Staphylococcus aureus on a burns unit through the intervention of an infection control bundle. Burns. 2013;39:395–403.PubMedCrossRef
94.
Jeanes A, Rao G, Osman M, Merrick P. Eradication of persistent environmental MRSA. J Hosp Infect. 2005;61:85–6.PubMedCrossRef
95.
Dryden M, Parnaby R, Dailly S, Lewis T, Davis-Blues K, Otter JA, et al. Hydrogen peroxide vapour decontamination in the control of a polyclonal meticillin-resistant Staphylococcus aureus outbreak on a surgical ward. J Hosp Infect. 2008;68:190–2.PubMedCrossRef
96.
Otter JA, Yezli S, Schouten MA, van Zanten AR, Houmes-Zielman G, Nohlmans-Paulssen MK. Hydrogen peroxide vapor decontamination of an intensive care unit to remove environmental reservoirs of multidrug-resistant gram-negative rods during an outbreak. Am J Infect Control. 2010;38:754–6.PubMedCrossRef
97.
Cooper T, O'Leary M, Yezli S, Otter JA. Impact of environmental decontamination using hydrogen peroxide vapour on the incidence of Clostridium difficile infection in one hospital Trust. J Hosp Infect. 2011;78:238–40.PubMedCrossRef
98.
Snitkin ES, Zelazny AM, Thomas PJ, Stock F, Henderson DK, Palmore TN, et al. Tracking a hospital outbreak of carbapenem-resistant Klebsiella pneumoniae with whole-genome sequencing. Sci Transl Med. 2012;4:148ra116.PubMedPubMedCentralCrossRef
99.
Gopinath R, Savard P, Carroll KC, Wilson LE, Landrum BM, Perl TM. Infection prevention considerations related to New Delhi metallo-beta-lactamase Enterobacteriaceae: a case report. Infect Control Hosp Epidemiol. 2013;34:99–100.PubMedCrossRef
100.
Otter JA, Nowakowski E, Salkeld JA, Duclos M, Passaretti CL, Yezli S, et al. Saving Costs through the Decontamination of the Packaging of Unused Medical Supplies Using Hydrogen Peroxide Vapor. Infect Control Hosp Epidemiol. 2013;34:472–8.PubMedCrossRef
101.
Otter JA, Barnicoat M, Down J, Smyth D, Yezli S, Jeanes A. Hydrogen peroxide vapour decontamination of a critical care unit room used to treat a patient with Lassa fever. J Hosp Infect. 2010;75:335–7.PubMedCrossRef
102.
Otter JA, Mepham S, Athan B, Mack D, Smith R, Jacobs M, et al. Terminal decontamination of the Royal Free London’s high-level isolation unit after a case of Ebola virus disease using hydrogen peroxide vapor. Am J Infect Control. 2016;44:233–5.PubMedCrossRef
103.
Otter JA, Puchowicz M, Ryan D, Salkeld JAG, Cooper TA, Havill NL, et al. Assessing the feasibility of routine use of hydrogen peroxide vapor (HPV) to decontaminate rooms in a busy US hospital. Infect Control Hosp Epidemiol. 2009;30:574–7.PubMedCrossRef
104.
Berrington AW, Pedler SJ. Investigation of gaseous ozone for MRSA decontamination of hospital side-rooms. J Hosp Infect. 1998;40:61–5.PubMedCrossRef
105.
de Boer HEL, van Elzelingen-Dekker CM, van Rheenen-Verberg CMF, Spanjaard L. Use of gaseous ozone for eradication of methicillin-resistant Staphylococcus aureus from the home environment of a colonized hospital employee. Infect Control Hosp Epidemiol. 2006;27:1120–2.PubMedCrossRef
106.
Sharma M, Hudson JB. Ozone gas is an effective and practical antibacterial agent. Am J Infect Control. 2008;36:559–63.PubMedCrossRef
107.
Davies A, Pottage T, Bennett A, Walker J. Gaseous and air decontamination technologies for Clostridium difficile in the healthcare environment. J Hosp Infect. 2011;77:199–203.PubMedCrossRef
108.
Gibbs SG, Lowe JJ, Smith PW, Hewlett AL. Gaseous chlorine dioxide as an alternative for bedbug control. Infect Control Hosp Epidemiol. 2012;33:495–9.PubMedCrossRef
109.
Sexton JD, Tanner BD, Maxwell SL, Gerba CP. Reduction in the microbial load on high-touch surfaces in hospital rooms by treatment with a portable saturated steam vapor disinfection system. Am J Infect Control. 2011;39:655–62.PubMedCrossRef
110.
Nernandzic MM, Cadnum JL, Pultz MJ, Donskey CJ. Evaluation of an automated ultraviolet radiation device for decontamination of Clostridium difficile and other healthcare-associated pathogens in hospital rooms. BMC Infect Dis. 2010;10:197.CrossRef
111.
Rutala WA, Gergen MF, Weber DJ. Room decontamination with UV radiation. Infect Control Hosp Epidemiol. 2010;31:1025–9.PubMedCrossRef
112.
Boyce JM, Havill NL, Moore BA. Terminal decontamination of patient rooms using an automated mobile UV light unit. Infect Control Hosp Epidemiol. 2011;32:737–42.PubMedCrossRef
113.
Rutala WA, Gergen MF, Tande BM, Weber DJ. Rapid hospital room decontamination using ultraviolet (UV) light with a nanostructured UV-reflective wall coating. Infect Control Hosp Epidemiol. 2013;34:527–9.PubMedCrossRef
114.
Anderson DJ, Gergen MF, Smathers E, Sexton DJ, Chen LF, Weber DJ, et al. Decontamination of targeted pathogens from patient rooms using an automated ultraviolet-C-emitting device. Infect Control Hosp Epidemiol. 2013;34:466–71.PubMedPubMedCentralCrossRef
115.
Mahida N, Vaughan N, Boswell T. First UK evaluation of an automated ultraviolet-C room decontamination device (Tru-D). J Hosp Infect. 2013;84:332–5.PubMedCrossRef
116.
Nerandzic MM, Fisher CW, Donskey CJ. Sorting through the wealth of options: comparative evaluation of two ultraviolet disinfection systems. PLoS One. 2014;9:e107444.PubMedPubMedCentralCrossRef
117.
Rutala WA, Gergen MF, Tande BM, Weber DJ. Room decontamination using an ultraviolet-C device with short ultraviolet exposure time. Infect Control Hosp Epidemiol. 2014;35:1070–2.PubMedCrossRef
118.
Rutala WA, Weber DJ, Gergen MF, Tande BM, Sickbert-Bennett EE. Does coating all room surfaces with an ultraviolet C light-nanoreflective coating improve decontamination compared with coating only the walls? Infect Control Hosp Epidemiol. 2014;35:323–5.PubMedCrossRef
119.
Havill NL, Moore BA, Boyce JM. Comparison of the microbiological efficacy of hydrogen peroxide vapor and ultraviolet light processes for room decontamination. Infect Control Hosp Epidemiol. 2012;33:507–12.PubMedCrossRef
120.
Anderson DJ, Sexton DJ. Effectiveness of enhanced terminal room disinfection to prevent healthcare-associated infections (HAIs). Clinical Trials.gov identifier: NCT01579370, 2015.
121.
Stibich M, Stachowiak J, Tanner B, Berkheiser M, Moore L, Raad I, et al. Evaluation of a pulsed-xenon ultraviolet room disinfection device for impact on hospital operations and microbial reduction. Infect Control Hosp Epidemiol. 2011;32:286–8.PubMedCrossRef
122.
Levin J, Riley LS, Parrish C, English D, Ahn S. The effect of portable pulsed xenon ultraviolet light after terminal cleaning on hospital-associated Clostridium difficile infection in a community hospital. Am J Infect Control. 2013;41:746–8.PubMedCrossRef
123.
Jinadatha C, Quezada R, Huber TW, Williams JB, Zeber JE, Copeland LA. Evaluation of a pulsed-xenon ultraviolet room disinfection device for impact on contamination levels of methicillin-resistant Staphylococcus aureus. BMC Infect Dis. 2014;14:187.PubMedPubMedCentralCrossRef
124.
Ghantoji SS, Stibich M, Stachowiak J, Cantu S, Adachi JA, Raad II, et al. Non-inferiority of pulsed xenon UV light versus bleach for reducing environmental Clostridium difficile contamination on high-touch surfaces in Clostridium difficile infection isolation rooms. J Med Microbiol. 2015;64:191–4.PubMedCrossRef
125.
Sander J, Ladenstein M. Reliability of disinfectant dispensers in hospitals (author’s transl). Dtsch Med Wochenschr. 1974;99:1560–4.PubMedCrossRef
126.
Nagaraja A, Visintainer P, Haas JP, Menz J, Wormser GP, Montecalvo MA. Clostridium difficile infections before and during use of ultraviolet disinfection. Am J Infect Control. 2015;43:940–5.CrossRef
127.
Miller R, Simmons S, Dale C, Stibich M, Stachowiak J. Utilization and impact of a pulsed-xenon ultraviolet room disinfection system and multidisciplinary care team on Clostridium difficile in a long-term acute care facility. Am J Infect Control. 2015;43:1350–3.PubMedCrossRef
128.
McMullen K, Wood H, Buol W, Johnson D, Bradley A, Woeltje K, et al. Impact of a pulsed xenon ultraviolet light (PX-UV) light room disinfection system on Clostridium difficile rates. Presented at IDWeek 2015, abstract 1714, October 10, 2015, San Diego, CA. 2015.
129.
Nerandzic MM, Thota P, Sankar CT, Jencson A, Cadnum JL, Ray AJ, et al. Evaluation of a pulsed xenon ultraviolet disinfection system for reduction of healthcare-associated pathogens in hospital rooms. Infect Control Hosp Epidemiol. 2015;36:192–7.PubMedCrossRef
130.
Maclean M, MacGregor SJ, Anderson JG, Woolsey GA, Coia JE, Hamilton K, et al. Environmental decontamination of a hospital isolation room using high-intensity narrow-spectrum light. J Hosp Infect. 2010;76:247–51.PubMedCrossRef
131.
Bache SE, Maclean M, MacGregor SJ, Anderson JG, Gettinby G, Coia JE, et al. Clinical studies of the High-Intensity Narrow-Spectrum light Environmental Decontamination System (HINS-light EDS), for continuous disinfection in the burn unit inpatient and outpatient settings. Burns. 2012;38:69–76.PubMedCrossRef
132.
Maclean M, McKenzie K, Anderson JG, Gettinby G, MacGregor SJ. 405 nm light technology for the inactivation of pathogens and its potential role for environmental disinfection and infection control. J Hosp Infect. 2014;88:1–11.PubMedCrossRef
133.
Cram N, Shipman N, Quarles JM. Reducing airborne microbes in the surgical operating theater & other clinical settings: A study utilizing the AiroCide System. J Clin Engineering. 2004;79–88.
Metadata
Title
Modern technologies for improving cleaning and disinfection of environmental surfaces in hospitals
Author
John M. Boyce
Publication date
01-12-2016
Publisher
BioMed Central
Published in
Antimicrobial Resistance & Infection Control / Issue 1/2016
Electronic ISSN: 2047-2994
DOI
https://doi.org/10.1186/s13756-016-0111-x

Other articles of this Issue 1/2016

Antimicrobial Resistance & Infection Control 1/2016 Go to the issue

Short report

Global variances in infection control practices for vancomycin resistant Enterococcus – results of an electronic survey

Research

Correlation between biofilm formation and resistance toward different commonly used antibiotics along with extended spectrum beta lactamase production in uropathogenic Escherichia coli isolated from the patients suspected of urinary tract infections visiting Shree Birendra Hospital, Chhauni, Kathmandu, Nepal

Research

First hospital outbreak of the globally emerging Candida auris in a European hospital

Research

Serious electronic games as behavioural change interventions in healthcare-associated infections and infection prevention and control: a scoping review of the literature and future directions

Review

Relationship between hospital ward design and healthcare-associated infection rates: a systematic review and meta-analysis

Research

Antimicrobial stewardship in long-term care facilities in Belgium: a questionnaire-based survey of nursing homes to evaluate initiatives and future developments

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits